首页> 外文期刊>Progress in Materials Science >Biologically modified nanoparticles as theranostic bionanomaterials
【24h】

Biologically modified nanoparticles as theranostic bionanomaterials

机译:生物改性的纳米粒子作为硫代硫代硫代硫代材料

获取原文
       

摘要

Inspired by natural biology, cell membrane-mimetic surface engineering and cell membrane camouflaging technology have been widely investigated. Notably, the cell membranecamouflaged nanoparticles (CM-NPs), which are produced by fusing synthetic nanoparticles with cellular membranes, gain unprecedented attention in biomedical fields. Compared with conventional nanosystems, these biomimetic nanoparticles (NPs) are bestowed with favored properties of elongated circulation time, immune evading and active targeting, which exhibit great potential in numerous biomedical applications and are anticipated to revolutionize the traditional nanomedicine. So far, a variety of cell membranes, along with expansive options of core materials, have been extensively investigated to construct the biomimetic system with unique functionalities. This review describes the evolution process from cell membrane-mimetic surface engineering to cell membrane camouflaging technology, which focuses on (I) cell membrane-mimetic surface engineering strategies (II) the fabrication of CM-NPs, (III) cell membrane-camouflaged nano-carriers, (VI) cell membrane camouflaged nano-phototherapeutic agents, (V) cell membrane camouflaged nano-antidotes, (VI) cell membrane camouflaged nanovaccines, (VII) cell membrane camouflaged nanoprobes, and (VIII) other relevant applications, providing an overview of the latest progress in the fabrication and application of cell membranebased biomimetic and highlighting the major challenges as well as opportunities in this field.
机译:受到天然生物学的启发,蜂窝模拟表面工程和细胞膜伪装技术已被广泛研究。值得注意的是,通过用细胞膜熔化合成纳米颗粒产生的细胞膜调瘤纳米颗粒(CM-NPS),在生物医学领域获得前所未有的注意。与常规纳米系统相比,这些仿生纳米颗粒(NPS)被赋予了细长循环时间,免疫逃离和活性靶向的有利性质,其在许多生物医学应用中表现出具有很大的潜力,并且预计将彻底改变传统的纳米医生。到目前为止,已经广泛研究了各种细胞膜,以及含有核心材料的膨胀方案,以构建具有独特功能的仿生体系。该综述描述了来自细胞膜模拟表面工程到细胞膜伪装技术的演化过程,专注于(i)细胞膜模拟表面工程策略(ii)CM-NPS的制造,(iii)细胞膜 - 伪装纳米 - 载体,(VI)细胞膜伪装纳米光治疗剂,(V)细胞膜伪装纳米抗体,(VI)细胞膜伪装纳米粒子,(VII)细胞膜伪装的纳米体,(VIII)其他相关应用,提供细胞膜基础的制造和应用的最新进展概述,并突出了这一领域的主要挑战以及机遇。

著录项

  • 来源
    《Progress in Materials Science》 |2021年第5期|100768.1-100768.53|共53页
  • 作者单位

    Shanghai Jiao Tong Univ Shanghai Inst Traumatol & Orthopaed Ruijin Hosp Sch Med Dept Orthopaed Shanghai Key Lab Prevent & Treatme 197 Ruijin 2nd Rd Shanghai 200025 Peoples R China;

    Harvard Univ John A Paulson Sch Engn & Appl Sci Cambridge MA 02138 USA;

    Harvard Med Sch Ctr Nanomed Brigham & Womens Hosp Boston MA 02115 USA|Harvard Med Sch Dept Anesthesiol Brigham & Womens Hosp Boston MA 02115 USA;

    Shanghai Jiao Tong Univ Shanghai Inst Traumatol & Orthopaed Ruijin Hosp Sch Med Dept Orthopaed Shanghai Key Lab Prevent & Treatme 197 Ruijin 2nd Rd Shanghai 200025 Peoples R China;

    Shanghai Jiao Tong Univ Shanghai Inst Traumatol & Orthopaed Ruijin Hosp Sch Med Dept Orthopaed Shanghai Key Lab Prevent & Treatme 197 Ruijin 2nd Rd Shanghai 200025 Peoples R China;

    Harvard Med Sch Ctr Nanomed Brigham & Womens Hosp Boston MA 02115 USA|Harvard Med Sch Dept Anesthesiol Brigham & Womens Hosp Boston MA 02115 USA;

    Harvard Med Sch Ctr Nanomed Brigham & Womens Hosp Boston MA 02115 USA|Harvard Med Sch Dept Anesthesiol Brigham & Womens Hosp Boston MA 02115 USA;

    Shanghai Jiao Tong Univ Shanghai Inst Traumatol & Orthopaed Ruijin Hosp Sch Med Dept Orthopaed Shanghai Key Lab Prevent & Treatme 197 Ruijin 2nd Rd Shanghai 200025 Peoples R China;

    Shanghai Jiao Tong Univ Shanghai Inst Traumatol & Orthopaed Ruijin Hosp Sch Med Dept Orthopaed Shanghai Key Lab Prevent & Treatme 197 Ruijin 2nd Rd Shanghai 200025 Peoples R China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Cell membrane; Surface engineering; Camouflaged nanoparticle; Bionanomaterial; Theranostic;

    机译:细胞膜;表面工程;伪装的纳米粒子;小烷烃;Theranostic;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号